series-a
Stage
1
Investors
About
Neurogene develops gene therapies to treat rare neurological disorders, with a primary focus on Rett syndrome and other neurodevelopmental diseases.
Explore Neurogene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.